Anti-Collagen II antibody [EPR12268]
- RabMAb
- Recombinant
- What is this?
5
(2 Reviews)
|
(135 Publications)
Rabbit Recombinant Monoclonal Collagen II antibody. Suitable for WB and reacts with Rat, Human samples. Cited in 135 publications.
View Alternative Names
Collagen alpha-1(II) chain, Alpha-1 type II collagen, COL2A1
- WB
Supplier Data
Western blot - Anti-Collagen II antibody [EPR12268] (AB188570)
Actual band size : 30 kDa (possible isoform or fragment).
Negative control : liver (PMID : 31553813, PMID : 9121483).
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Collagen II antibody [EPR12268] (ab188570) at 1/5000 dilution
Lane 1:
Rat articular cartilage lysate at 20 µg
Lane 2:
Rat liver lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 30 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-Collagen II antibody [EPR12268] (AB188570)
Actual band size : 36kDa (His-tagged recombinant fragment 1242-1487 aa purified from HEK293 cells)
All lanes:
Western blot - Anti-Collagen II antibody [EPR12268] (ab188570) at 1/1000 dilution
All lanes:
Human Collagen II recombinant protein at 0.01 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 141 kDa
Observed band size: 36 kDa
false
- WB
Lab
Western blot - Anti-Collagen II antibody [EPR12268] (AB188570)
Actual band size : 30kDa (possible isoform or fragment) Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Collagen II antibody [EPR12268] (ab188570) at 1/5000 dilution
Lane 1:
Rat cartilage lysate at 20 µg
Lane 2:
Human cartilage lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 141 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Fibrillar collagen type II is an important component of the extracellular matrix important for endochondral ossification and cartilage formation. Collagen type II forms a network that interacts with other ECM molecules such as proteoglycans and non-collagenous proteins creating a hydrated gel that resists compressive forces. This complex structure is essential for maintaining the biomechanical properties of cartilage enabling it to withstand mechanical stress and support smooth joint movements.
Pathways
Collagen type II plays an important role in cartilage development and homeostasis. It is integral to the TGF-β signaling pathway which regulates cell growth and differentiation in chondrocytes. The protein is related to other collagens such as collagen type IX and proteoglycans like aggrecan both of which contribute to the structural integrity of cartilage. These interactions facilitate the proper assembly and organization of cartilage ECM supporting tissue function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (135)
Recent publications for all applications. Explore the full list and refine your search
Journal of microbiology and biotechnology 35:e2506035 PubMed41016815
2025
Applications
Unspecified application
Species
Unspecified reactive species
Innovation (Cambridge (Mass.)) 6:100913 PubMed40697780
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic translation 53:187-205 PubMed40678612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic translation 52:220-232 PubMed40337550
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 31:128 PubMed40197110
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 17:75-86 PubMed39959196
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e70064 PubMed39569601
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:634 PubMed39420311
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e70027 PubMed39159149
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eado7249 PubMed39151007
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com